A comparison of vaginal misoprostol 800 microg versus 400 microg for anembryonic pregnancy: a randomized comparative trial
- PMID: 17722316
A comparison of vaginal misoprostol 800 microg versus 400 microg for anembryonic pregnancy: a randomized comparative trial
Abstract
Objective: To compare the efficacy, side effects and patient satisfaction between 800 microg versus 400 microg intravaginal misoprostol for anembryonic pregnancy.
Material and method: Women who had diagnosed as anembryonic pregnancy were treated as IPD case and randomly assigned to receive either 800 microg or 400 microg intravaginal misoprostol. The second dose was administered in the equal dose if there was no evidence of abortion in 24 hr. The treatment failure was determined by no complete abortion within 48 hr. If spontaneous abortion had not occurred, or had heavy vaginal bleeding or evidence of incomplete abortion either by clinical manifestation or sonographic finding then dilatation and curettage was performed.
Results: Fifty patients were enrolled into the study, 25 patients were randomized to receive 800 mg and 25 patients were received 400 mg intravaginal misoprostol. Complete abortion within 48 hr was not different between the 2 groups (72%). However complete abortion within 12 hr was significantly higher in the 800 mg group than in the 400 mg group (64% versus 20%, respectively, p = 0.016). The median time to abortion in the 800 mg group was significantly shorter than in the 400 mg group (9.0 hr versus 16.0 hr, respectively, p = 0.01). There was no significant difference in the side effects and patients' satisfaction between both groups.
Conclusion: Vaginal misoprostol can be used for termination of pregnancy in case of anembryonic pregnancy with high successful rate of complete abortion and no serious adverse effects. We recommend the 800 microg vaginal misoprostol regimen because within 12 hr the complete abortion rate was higher and the median time to abortion was shorter than the 400 microg regimen with no difference in side effects. This may decrease the suffering time of both physical and psychological trauma to the patient before complete abortion has occurred.
Similar articles
-
Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.J Obstet Gynaecol Res. 2009 Feb;35(1):78-85. doi: 10.1111/j.1447-0756.2008.00864.x. J Obstet Gynaecol Res. 2009. PMID: 19215552 Clinical Trial.
-
A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.Aust N Z J Obstet Gynaecol. 2008 Apr;48(2):165-71. doi: 10.1111/j.1479-828X.2008.00831.x. Aust N Z J Obstet Gynaecol. 2008. PMID: 18366490 Clinical Trial.
-
Sublingual versus vaginal misoprostol for cervical ripening PRIOR TO manual vacuum aspiration under local anaesthesia: a randomized study.Eur J Contracept Reprod Health Care. 2007 Dec;12(4):372-7. doi: 10.1080/13625180701549758. Eur J Contracept Reprod Health Care. 2007. PMID: 17853158 Clinical Trial.
-
The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion.Contraception. 2006 Jul;74(1):26-30. doi: 10.1016/j.contraception.2006.03.005. Epub 2006 Apr 27. Contraception. 2006. PMID: 16781256 Review.
-
Evidence for shortening the time interval of prostaglandin after mifepristone for medical abortion.Contraception. 2006 Jul;74(1):42-4. doi: 10.1016/j.contraception.2006.03.014. Epub 2006 May 12. Contraception. 2006. PMID: 16781259 Review.
Cited by
-
Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD002253. doi: 10.1002/14651858.CD002253.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2019 Jun 17;6:CD002253. doi: 10.1002/14651858.CD002253.pub4. PMID: 16855990 Free PMC article. Updated.
-
Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD002253. doi: 10.1002/14651858.CD002253.pub4. Cochrane Database Syst Rev. 2019. PMID: 31206170 Free PMC article.
-
Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis.Sci Rep. 2017 May 10;7(1):1664. doi: 10.1038/s41598-017-01892-0. Sci Rep. 2017. PMID: 28490770 Free PMC article.
-
Methods for managing miscarriage: a network meta-analysis.Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD012602. doi: 10.1002/14651858.CD012602.pub2. Cochrane Database Syst Rev. 2021. PMID: 34061352 Free PMC article.